 Off-label prescriptions account for a large percentage of drug sales and physicians often desire and value information about off-label uses. However, strict rules limit how sales representatives can discuss off-label uses with physicians.
This module covers the rules around discussing off-label uses, including the high consequences of non-compliance, such as a recent $430 million penalty for one drug company. It includes practical selling tips and case studies to help reps understand the compliance challenges they face when selling to physicians.
To find about each course in our compliance curriculum, click on one of the topics shown or click the button below to view a sample course.
 (Off-Label Regulations Demo)
|
